Sharps Technology raises over $400 million to buy Solana cryptocurrency

Sharps Technology Inc. (NASDAQ: STSS) completed a private placement offering that raised over $400 million in gross proceeds, the medical device company announced. The transaction could generate up to $1 billion if all associated warrants are exercised.

The company sold common stock and warrants at $6.50 per unit. Investors included financial institutions and digital asset firms such as ParaFi, Pantera, Monarq, FalconX, Bastion Trading, and Saba Capital.

Sharps Technology plans to use the proceeds primarily to purchase SOL, the native digital asset of the Solana blockchain, establishing a digital asset treasury strategy. The company will allocate additional funds to working capital and general corporate purposes.

The company signed a non-binding letter of intent with the Solana Foundation to purchase $50 million of SOL at a 15% discount to a 30-day time-weighted average price. This purchase would occur using proceeds from a public offering, subject to certain conditions.

"Solana is capable of handling any tradable asset, everywhere in the world, and demand is only increasing," said Alice Zhang, Chief Investment Officer and Board Member of Sharps Technology.

Cantor Fitzgerald & Co. served as lead placement agent, while Aegis Capital Corp. acted as co-placement agent for the transaction.

Sharps Technology operates as a medical device and pharmaceutical packaging company, offering safety syringe products to the healthcare industry. The company stated it plans to maintain its existing medical device distribution business operations while pursuing the digital asset strategy.

The information is based on a company press release statement.

You May Also Be Interested In

• Non-Invasive Monitoring Systems files to offer 8.1M shares
• Baosheng signs non-binding MOU with 58.com for AI marketing
• BitGo Korea wins VASP registration in South Korea